OS
Clinical trials for OS explained in plain language.
Never miss a new study
Get alerted when new OS trials appear
Sign up with your email to follow new studies for OS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New combo therapy aims to cut relapse in rare lymphoma
Disease control ENROLLING_BY_INVITATIONThis study tests whether adding the drug tislelizumab to standard chemotherapy and radiation can improve outcomes for people with early-stage NK/T-cell lymphoma, a rare blood cancer. About 60 adults aged 18 to 70 will receive the combination treatment. The goal is to see if this …
Matched conditions: OS
Sponsor: Eye & ENT Hospital of Fudan University • Aim: Disease control
Last updated Jun 27, 2026 09:11 UTC
-
New hope for rare sinus cancer: combined therapy shows promise
Disease control ENROLLING_BY_INVITATIONThis study tests a treatment plan for adults with a rare cancer of the nasal and sinus cavities called rhabdomyosarcoma. The plan involves chemotherapy and radiation before and after surgery. The goal is to see if this approach can shrink tumors and improve survival. The study wi…
Matched conditions: OS
Sponsor: Eye & ENT Hospital of Fudan University • Aim: Disease control
Last updated Jun 27, 2026 09:10 UTC